0.727
Schlusskurs vom Vortag:
$0.76
Offen:
$0.7698
24-Stunden-Volumen:
364.21K
Relative Volume:
5.72
Marktkapitalisierung:
$69.86M
Einnahmen:
$8.88M
Nettoeinkommen (Verlust:
$-4.62M
KGV:
-10.82
EPS:
-0.0672
Netto-Cashflow:
$-2.66M
1W Leistung:
-17.28%
1M Leistung:
-27.29%
6M Leistung:
-17.39%
1J Leistung:
+6.91%
Milestone Scientific Inc. Stock (MLSS) Company Profile
Firmenname
Milestone Scientific Inc.
Sektor
Telefon
973-535-2717
Adresse
220 South Orange Avenue, Livingston, NJ
Vergleichen Sie MLSS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MLSS
Milestone Scientific Inc.
|
0.727 | 69.86M | 8.88M | -4.62M | -2.66M | -0.0672 |
![]()
ISRG
Intuitive Surgical Inc
|
533.71 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
170.86 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.81 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
255.16 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
218.87 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-09-16 | Eingeleitet | Northland Capital | Market Perform |
2018-11-16 | Bestätigt | Maxim Group | Buy |
2016-12-23 | Bestätigt | Maxim Group | Buy |
2015-12-11 | Eingeleitet | Maxim Group | Buy |
Milestone Scientific Inc. Aktie (MLSS) Neueste Nachrichten
Thai Research Breakthrough Published in International Scientific Journal A Milestone of Success - Yahoo Finance
Major Shareholder Sells Thousands of Milestone Scientific Shares! - TipRanks
Milestone Scientific’s major shareholder sells $21,464 in stock - Investing.com Australia
Major Shareholder Makes a Bold Move with Milestone Scientific Stock! - TipRanks
Kalkine : NYSE Composite Sees MLSS Movement Amid Light Trading Volume - Kalkine Media
Milestone Scientific sees $78,713 stock sale by BP4 S.r.l. - Investing.com Canada
Milestone Scientific (NYSE:MLSS) Trading Down 0.5% – Here’s What Happened - Defense World
Major Shareholder Sells Off Thousands of Milestone Scientific Shares! - TipRanks
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
Milestone scientific shareholder BP4 S.r.l. sells $12,963 in stock By Investing.com - Investing.com India
Milestone scientific shareholder BP4 S.r.l. sells $12,963 in stock - Investing.com
Major Shareholder Sheds Milestone Scientific Stock in Noteworthy Transaction - TipRanks
Inter Scientific Achieves UK GLP Monitoring Authority Status to Support Regulatory Studies for Medicines, Devices and Novel Products - FinancialContent
Milestone Scientific Reports Increased Quarterly Loss - TipRanks
Benchmark maintains $1.25 target on Milestone Scientific stock - Investing.com
Benchmark maintains $1.25 target on Milestone Scientific stock By Investing.com - Investing.com India
Milestone Scientific adds new board member to drive growth By Investing.com - Investing.com South Africa
Milestone Scientific adds new board member to drive growth - Investing.com Australia
Milestone Scientific Appoints New Independent Director - TipRanks
Milestone Scientific Appoints Highly Accomplished MedTech Execut - GuruFocus
Milestone Scientific Inc. Appoints Shanth Thiyagalingam to Board of Directors to Enhance Strategic Growth and Innovation - Nasdaq
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors - GlobeNewswire
Milestone Scientific Lands PainTEQ CEO to Drive Medicare Reimbursement Strategy - Stock Titan
StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS) - Defense World
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025 - The Manila Times
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025 | MLSS Stock News - GuruFocus
Milestone Scientific Medical Sales Surge 586% After Medicare Coverage Win for CompuFlo System - Stock Titan
Rigetti Shares Down 15% Post Q1 Earnings: Time to Buy, Hold or Sell? - TradingView
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data - The Manila Times
Nexalin Technology Reconstitutes Scientific Advisory Board - GlobeNewswire
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data - The Globe and Mail
StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS) - Defense World
Space explorationMilestones, Achievements, History - Britannica
Space exploration | History, Definition, & Facts - Britannica
Renaissance Technologies LLC Buys 53,198 Shares of Milestone Scientific Inc. (NYSE:MLSS) - Defense World
Envestnet Asset Management Inc. Takes $203,000 Position in Universal Technical Institute, Inc. (NYSE:UTI) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com - Defense World
Milestone Scientific Announces Pricing of Above Market $4.5 Million Offering of Common Stock and Warrants - ACCESS Newswire
Milestone Scientific Inc. to Host Earnings Call - ACCESS Newswire
Protara Therapeutics, Inc. (NASDAQ:TARA) Shares Sold by LPL Financial LLC - Defense World
Pre-market Movers: STSS, THRD, PTN, VRAX... - RTTNews
Commentary: This genetics firm didn't resurrect the extinct dire wolf, but did achieve a breakthrough in hype - Los Angeles Times
Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com - Defense World
Benchmark maintains Buy on Milestone Scientific, $1.25 target By Investing.com - Investing.com South Africa
Benchmark maintains Buy on Milestone Scientific, $1.25 target - Investing.com Australia
Charles & Colvard, Ltd. Announces Delisting from Nasdaq - Quantisnow
Finanzdaten der Milestone Scientific Inc.-Aktie (MLSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Milestone Scientific Inc.-Aktie (MLSS) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
BP4 S.r.l. | 10% Owner |
Jun 10 '25 |
Sale |
0.91 |
30,100 |
27,373 |
9,481,036 |
BP4 S.r.l. | 10% Owner |
Jun 09 '25 |
Sale |
0.91 |
20,266 |
18,341 |
9,511,136 |
BP4 S.r.l. | 10% Owner |
Jun 06 '25 |
Sale |
0.90 |
60,200 |
54,264 |
9,531,402 |
BP4 S.r.l. | 10% Owner |
Jun 05 '25 |
Sale |
0.91 |
26,855 |
24,449 |
9,591,602 |
BP4 S.r.l. | 10% Owner |
Jun 03 '25 |
Sale |
0.94 |
8,000 |
7,495 |
9,624,457 |
BP4 S.r.l. | 10% Owner |
Jun 04 '25 |
Sale |
0.91 |
6,000 |
5,468 |
9,618,457 |
BP4 S.r.l. | 10% Owner |
May 30 '25 |
Sale |
0.93 |
12,118 |
11,278 |
9,642,457 |
BP4 S.r.l. | 10% Owner |
Jun 02 '25 |
Sale |
0.95 |
10,000 |
9,466 |
9,632,457 |
BP4 S.r.l. | 10% Owner |
May 28 '25 |
Sale |
0.96 |
14,256 |
13,686 |
9,658,192 |
BP4 S.r.l. | 10% Owner |
May 29 '25 |
Sale |
0.96 |
3,361 |
3,227 |
9,654,831 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):